Webinar recording available: COVID-19 and obesity: a public health perspective, 30 July

For more information click here.

Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO. None of the speakers have received a fee for their participation in this webinar, and ASO has been fully responsible for engaging with the participants.  

Comments are closed.